Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of age

Type B ◽

Fourth Dose

IMMUNE RESPONSE AND ONE-YEAR ANTIBODY PERSISTENCE AFTER A FOURTH DOSE OF A NOVEL HAEMOPHILUS INFLUENZAE TYPE B AND NEISSERIA MENINGITIDIS SEROGROUPS C AND Y-TETANUS TOXOID CONJUGATE VACCINE (HibMenCY) AT 12 TO 15 MONTHS OF AGE

10.1097/inf.0b013e3181cdd379 ◽

2010 ◽

Vol 29 (5) ◽

pp. 469-471 ◽

Cited By ~ 20

Author(s):

Gary S. Marshall ◽

Colin D. Marchant ◽

Mark Blatter ◽

Emmanuel Aris ◽

Dominique Boutriau ◽

...

Keyword(s):

Immune Response ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Tetanus Toxoid ◽

Type B ◽

Antibody Persistence ◽

Fourth Dose ◽

One Year

Antibody Persistence for up to 5 Years After a Fourth Dose of Haemophilus influenzae Type b and Neisseria Meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT) Given at 12–15 Months of Age

10.1097/inf.0b013e3182840e35 ◽

2013 ◽

Vol 32 (6) ◽

pp. 662-668 ◽

Cited By ~ 8

Author(s):

Gary S. Marshall ◽

Mark Blatter ◽

Colin Marchant ◽

Emmanuel Aris ◽

Narcisa Mesaros ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B ◽

Antibody Persistence ◽

Fourth Dose

IMMEDIATE AND LONGER TERM IMMUNOGENICITY OF A SINGLE DOSE OF THE COMBINED HAEMOPHILUS INFLUENZAE TYPE B-NEISSERIA MENINGITIDIS SEROGROUP C-TETANUS TOXOID CONJUGATE VACCINE IN PRIMED TODDLERS 12 TO 18 MONTHS OF AGE

10.1097/inf.0b013e31820013d2 ◽

2011 ◽

Vol 30 (4) ◽

pp. 340-342 ◽

Cited By ~ 12

Author(s):

Robert Booy ◽

Peter Richmond ◽

Terry Nolan ◽

Jodie McVernon ◽

Helen Marshall ◽

...

Keyword(s):

Single Dose ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B

Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers

10.1097/inf.0000000000000898 ◽

2015 ◽

Vol 34 (12) ◽

pp. 1379-1384 ◽

Cited By ~ 4

Author(s):

Robert Booy ◽

Terry Nolan ◽

Graham Reynolds ◽

Peter Richmond ◽

Michael Nissen ◽

...

Keyword(s):

Single Dose ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B ◽

Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine

10.1097/inf.0b013e318269433a ◽

2012 ◽

pp. 1 ◽

Cited By ~ 2

Author(s):

Juan Carlos Tejedor ◽

José Manuel Merino ◽

Manuel Moro ◽

Maria-Luisa Navarro ◽

José Espín ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Booster Dose ◽

Type B ◽

Faculty Opinions recommendation of Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962180.793465807 ◽

2012 ◽

Author(s):

Susan Coffin

Keyword(s):

Single Dose ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B ◽

Faculty Opinions recommendation of A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969130.793469931 ◽

2013 ◽

Author(s):

Susan Coffin

Keyword(s):

Hepatitis B ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Controlled Study ◽

Type B ◽

Randomized Controlled

Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine

10.1097/inf.0b013e3181fcb2bf ◽

2011 ◽

Vol 30 (3) ◽

pp. 190-196 ◽

Cited By ~ 23

Author(s):

Terry Nolan ◽

Peter Richmond ◽

Helen Marshall ◽

Jodie McVernon ◽

Karyn Alexander ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B

Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine in Infants

10.1097/inf.0b013e3181c3ce88 ◽

2010 ◽

Vol 29 (1) ◽

pp. 48-52 ◽

Cited By ~ 22

Author(s):

Colin D. Marchant ◽

Jacqueline M. Miller ◽

Gary S. Marshall ◽

Mark Blatter ◽

Emmanuel Aris ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Randomized Trial ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B

Immunogenicity and Reactogenicity of a Booster Dose of a Novel Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine Given to Toddlers of 13–14 Months of Age With Antibody Persistence Up to 31 Months of Age

10.1097/inf.0b013e31816b4561 ◽

2008 ◽

Vol 27 (7) ◽

pp. 579-588 ◽

Cited By ~ 26

Author(s):

Juan C. Tejedor ◽

Manuel Moro ◽

José Manuel Merino ◽

José Antonio Gómez-Campderá ◽

Manuel García-del-Rio ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Booster Dose ◽

Type B ◽